Juan Collazo-Jaloma
Overview
Explore the profile of Juan Collazo-Jaloma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramos-Penafiel C, Olarte-Carrillo I, Ceron Maldonado R, De la Cruz Rosas A, Collazo-Jaloma J, Martinez-Tovar A
Ann Hematol
. 2020 Sep;
99(11):2629-2637.
PMID: 32980890
Treatment of acute lymphoblastic leukemia (ALL) requires the combination of multiple drugs to integrate a complete remission. The different prognostic factors (age, leukocytes, risk, cytogenetic alterations) allow identifying those patients...
2.
Ramos-Penafiel C, Olarte-Carrillo I, Ceron-Maldonado R, Rozen-Fuller E, Kassack-Ipina J, Melendez-Mier G, et al.
J Transl Med
. 2018 Sep;
16(1):245.
PMID: 30176891
Background: In acute lymphoblastic leukemia (ALL), high ABCB1 gene expression has been associated with treatment resistance, which affects patient prognosis. Many preclinical reports and retrospective population studies have shown an...
3.
Santoyo-Sanchez A, Ramos-Penafiel C, Saavedra-Gonzalez A, Gonzalez-Almanza L, Martinez-Tovar A, Olarte-Carrillo I, et al.
Gac Med Mex
. 2017 Jan;
153(1):44-48.
PMID: 28128805
Introduction: In developing countries, there is commonly a lack of population-based cancer registries or underreporting, thus not recognizing the true dimensions of the problem. Aim: To describe the age and...
4.
Santoyo-Sanchez A, Ramos-Penafiel C, Saavedra-Gonzalez A, Gonzalez-Almanza L, Martinez-Tovar A, Olarte-Carrillo I, et al.
Gac Med Mex
. 2016 May;
152(2):208-12.
PMID: 27160620
Introduction: A lack of a population-based cancer registry or underreporting is common in developing countries, without knowledge of the true dimensions of the problem. Aim: To describe the age and...
5.
Ramos-Penafiel C, Cabrera-Garcia A, Rozen-Fuller E, Gonzalez-Leon G, Balderas C, Kassack-Ipina J, et al.
Rev Peru Med Exp Salud Publica
. 2014 Nov;
31(3):525-9.
PMID: 25418653
In order to assess the mortality and toxicity of the Hyper-CVAD protocol used as first-line treatment of acute lymphoblastic leukemia, a retrospective cohort study was performed in patients less than...
6.
Ramos-Penafiel C, Martinez-Murillo C, Santoyo-Sanchez A, Jimenez-Ponce F, Rozen-Fuller E, Collazo-Jaloma J, et al.
Rev Med Inst Mex Seguro Soc
. 2014 Jun;
52(3):270-5.
PMID: 24878085
Background: Recently it has been reported a benefit effect with the use of metformin in patients with malignant disease. Our objective was to evaluate the effect of adding metformin to...
7.
Santoyo-Sanchez A, Ramos-Penafiel C, Palmeros-Morgado G, Mendoza-Garcia E, Olarte-Carrillo I, Martinez-Tovar A, et al.
Rev Med Inst Mex Seguro Soc
. 2014 Apr;
52(2):176-81.
PMID: 24758856
Background: In 2009, 17.9 % of hospital morbidity by malignant tumors in México corresponded to hematological malignancies, mainly acute leukemia. Some studies suggest a seasonal pattern, since most of the...
8.
Peniche-Alvarado C, Ramos-Penafiel C, Martinez-Murillo C, Romero-Guadarrama M, Olarte-Carrillo I, Rozen-Fuller E, et al.
Rev Med Inst Mex Seguro Soc
. 2013 Oct;
51(5):502-5.
PMID: 24144143
Background: lymphoma is the most frequent lymphoid neoplasm in our country. Its diagnosis is based on histopathological findings. The lymph node imprint has been used for more than 40 years....
9.
Olarte I, Martinez A, Ramos-Penafiel C, Castellanos-Sinco H, Zamora J, Collazo-Jaloma J, et al.
Hematology
. 2011 Dec;
16(6):368-72.
PMID: 22183072
This study evaluates the prognostic value of MAGE-A3 expression in 28 diffuse large B-cell lymphoma (DLBCL) patients. A significant association was observed between MAGE-A3 expressions, assessed by quantitative real-time RT-polymerase...
10.
Ambriz-Fernandez R, Martinez-Murillo C, Quintana-Gonzalez S, Collazo-Jaloma J
Arch Med Res
. 2002 Dec;
33(6):536-40.
PMID: 12505098
Background: This is an evaluation of the treatment of 63 patients with chronic immune thrombocytopenic purpura (54 splenectomized and nine nonsplenectomized) with weekly doses of anti-D (IgG)-coated red blood cells...